Literature DB >> 23155670

A clinican's guide to adult attention-deficit hyperactivity disorder.

Vania Modesto-Lowe1, Andrea Meyer, Victoria Soovajian.   

Abstract

While attention-deficit hyperactivity disorder (ADHD) has been traditionally viewed as a childhood ailment, longitudinal data suggest that it persists into adulthood for most affected individuals. Adult ADHD is now recognized as a legitimate diagnosis with clinical and epidemiological implications. It is estimated that 4% of American adults are afflicted by this disorder. There have been advances in adultADHD screening tools, diagnostic guidelines, medication delivery systems and psychosocial treatments. Despite these gains, there is great variability among clinicians in the diagnosis and treatment of adult ADHD. This article reviews controversies surrounding the diagnosis and treatment of adult ADHD and suggests strategies to overcome existing obstacles.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23155670

Source DB:  PubMed          Journal:  Conn Med        ISSN: 0010-6178


  3 in total

Review 1.  A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.

Authors:  Martin A Katzman; Tia Sternat
Journal:  CNS Drugs       Date:  2014-11       Impact factor: 5.749

Review 2.  Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis.

Authors:  Hui Liu; Wenjing Feng; Dongfeng Zhang
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-08-24       Impact factor: 4.785

Review 3.  Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management.

Authors:  Henry A Spiller; Hannah L Hays; Alfred Aleguas
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.